Back to calendar
Corvus Pharmaceuticals, Inc. (CRVS) Earnings
CRVS reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.18
Actual EPS: $-0.19
EPS surprise: -19.40%
Company overview
Market Cap$1.2B
PriceUSD 13.79
EPS (TTM)-0.53
52-week high26.95
52-week low4.26
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees37